Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study

J Alzheimers Dis. 2020;74(3):865-874. doi: 10.3233/JAD-191315.

Abstract

Background: Seizures are common in patients with dementia but precise epidemiologic data of epilepsy in neurodegenerative dementia is lacking.

Objective: The first aim of the study was to investigate prevalence and clinical characteristics of epilepsy in a large cohort of patients with neurodegenerative dementias. Subsequently, we explored clinical, neuropsychological, and quantitative electroencephalogram (qEEG) data of Alzheimer's disease (AD) patients with epilepsy (AD-EPI) as compared to AD patients without epilepsy (AD-CTR).

Methods: We retrospectively evaluated consecutive patients with a diagnosis of a neurodegenerative dementia and a clinically diagnosed epilepsy that required antiepileptic drugs (AED). All patients underwent baseline comprehensive neuropsychological assessment. A follow-up of at least one year was requested to confirm the dementia diagnosis. In AD patients, qEEG power band analysis was performed. AD-CTR and AD-EPI patients were matched for age, Mini-Mental State Examination score, and gender.

Results: Thirty-eight out of 2,054 neurodegenerative dementia patients had epilepsy requiring AED. The prevalence of epilepsy was 1.82% for AD, 1.28% for the behavioral variant of frontotemporal dementia (bvFTD), 2.47% for dementia with Lewy bodies (DLB), and 12% for primary progressive aphasia. Epilepsy were more drug-responsive in AD than in non-AD dementias. Finally, no significant differences were found in neuropsychological and qEEG data between AD-EPI and AD-CTR patients.

Conclusion: In our cohort, AD, FTD, and DLB dementias have similar prevalence of epilepsy, even if AD patients were more responsive to AED. Moreover, AD-EPI patients did not have significant clinical, neuropsychological qEEG differences compared with AD-CTR patients.

Keywords: Alzheimer’s disease; EEG; dementia; epilepsy; seizure.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / complications
  • Alzheimer Disease / epidemiology
  • Alzheimer Disease / physiopathology
  • Anticonvulsants / therapeutic use
  • Cohort Studies
  • Dementia / complications*
  • Dementia / epidemiology
  • Dementia / physiopathology
  • Electroencephalography*
  • Epilepsy / epidemiology
  • Epilepsy / etiology*
  • Epilepsy / physiopathology
  • Female
  • Frontotemporal Dementia / complications
  • Frontotemporal Dementia / epidemiology
  • Frontotemporal Dementia / physiopathology
  • Humans
  • Lewy Body Disease / complications
  • Lewy Body Disease / epidemiology
  • Lewy Body Disease / physiopathology
  • Magnetic Resonance Imaging
  • Male
  • Mental Status and Dementia Tests
  • Middle Aged
  • Neurodegenerative Diseases / complications*
  • Neurodegenerative Diseases / epidemiology
  • Neurodegenerative Diseases / physiopathology
  • Neuropsychological Tests
  • Positron Emission Tomography Computed Tomography
  • Prevalence

Substances

  • Anticonvulsants